Skip to main content
Top
Published in: International Journal of Clinical Pharmacy 2/2016

01-04-2016 | Research Article

Qatar pharmacists’ understanding, attitudes, practice and perceived barriers related to providing pharmaceutical care

Authors: Maguy Saffouh El Hajj, Hassna Sohil AL-Saeed, Maryam Khaja

Published in: International Journal of Clinical Pharmacy | Issue 2/2016

Login to get access

Abstract

Background Pharmaceutical care (PC) is the philosophy of practice that includes identifying and resolving medication therapy problems to improve patient outcomes. Objectives The study objectives were to examine the extent of pharmaceutical care practice and the barriers to pharmaceutical care provision as perceived by Qatar pharmacists and to assess their level of understanding of pharmaceutical care and their attitudes about pharmaceutical care provision. Setting Qatar pharmacies. Methods A cross sectional survey of all pharmacists in Qatar was made. Consenting pharmacists were given the option to complete the survey either online using an online software or as paper by fax or by hand. Main outcome measures 1. Extent of pharmaceutical care practice in Qatar. 2. Barriers to pharmaceutical care provision in Qatar. 3. Qatar pharmacists’ level of understanding of pharmaceutical care. 4. Qatar pharmacists’ attitudes toward pharmaceutical care provision. Results Over 8 weeks, 274 surveys were collected (34 % response rate). More than 80 % of respondents had correct understanding of the aim of PC and of the pharmacist role in PC. However, only 47 % recognized the patient role in PC and only 35 % were aware of the differences between clinical pharmacy and PC. Yet, more than 80 % believed that they could be advocates when it comes to patients’ medications and health matters. Concerning their practice, respondents reported spending little time on PC activities. Offering feedback to the physician about the patient progress was always or most of the time performed by 21 % of respondents. The top perceived barriers for PC provision included inconvenient access to patient medical information (78 %) and lack of staff and time (77 and 74 % respectively). Conclusions Although PC is not incorporated into pharmacy practice, Qatar pharmacists showed positive attitudes toward PC provision. Further work should focus on improving their PC understanding and on overcoming all barriers.
Appendix
Available only for authorised users
Literature
1.
go back to reference Cipolle R, Strand L, Morley P. Pharmaceutical care practice: the patient-centered approach to medication management. McGraw-Hill Medical; 2012. (ISBN-13: 978-0071756389). Cipolle R, Strand L, Morley P. Pharmaceutical care practice: the patient-centered approach to medication management. McGraw-Hill Medical; 2012. (ISBN-13: 978-0071756389).
2.
go back to reference Odedina FT, Segal R. Behavioral pharmaceutical care scale for measuring pharmacist’s activities. Am J Health Syst Pharm. 1996;53:855–65.PubMed Odedina FT, Segal R. Behavioral pharmaceutical care scale for measuring pharmacist’s activities. Am J Health Syst Pharm. 1996;53:855–65.PubMed
3.
go back to reference Ernst F, Grizzle AJ. Drug-related morbidity and mortality: updating the cost-of-illness model. J Am Pharm Assoc. 2001;41(2):192–9.CrossRef Ernst F, Grizzle AJ. Drug-related morbidity and mortality: updating the cost-of-illness model. J Am Pharm Assoc. 2001;41(2):192–9.CrossRef
4.
go back to reference Davies EC, Green CF, Taylor S, Williamson PR, Mottram DR, Pirmohamed M. Adverse drug reactions in hospital in-patients: a prospective analysis of 3695 patient-episodes. PLoS One. 2009;4(2):e4439.CrossRefPubMedPubMedCentral Davies EC, Green CF, Taylor S, Williamson PR, Mottram DR, Pirmohamed M. Adverse drug reactions in hospital in-patients: a prospective analysis of 3695 patient-episodes. PLoS One. 2009;4(2):e4439.CrossRefPubMedPubMedCentral
5.
go back to reference Westerlund T, Marklund B. Assessment of the clinical and economic outcomes of pharmacy interventions in drug related problems. J Clin Pharm Ther. 2009;34:319–27.CrossRefPubMed Westerlund T, Marklund B. Assessment of the clinical and economic outcomes of pharmacy interventions in drug related problems. J Clin Pharm Ther. 2009;34:319–27.CrossRefPubMed
6.
go back to reference Beney J, Bero LA, Bond C. Expanding the roles of outpatient pharmacists: effects on health services utilization, costs, and patient outcomes. Cochrane Database Syst Rev. 2000;3:CD000336.PubMed Beney J, Bero LA, Bond C. Expanding the roles of outpatient pharmacists: effects on health services utilization, costs, and patient outcomes. Cochrane Database Syst Rev. 2000;3:CD000336.PubMed
8.
go back to reference Tan EC, Stewart K, Elliott RA, George J. Pharmacist services provided in general practice clinics: a systematic review and meta-analysis. Res Social Adm Pharm. 2014;10(4):608–22.CrossRefPubMed Tan EC, Stewart K, Elliott RA, George J. Pharmacist services provided in general practice clinics: a systematic review and meta-analysis. Res Social Adm Pharm. 2014;10(4):608–22.CrossRefPubMed
9.
go back to reference International Pharmaceutical Federation. FIP statement of professional standards pharmaceutical care, 1998. International Pharmaceutical Federation. FIP statement of professional standards pharmaceutical care, 1998.
11.
go back to reference Christensen DB, Farris KB. Pharmaceutical care in community pharmacies: practice and research in the US. Ann Pharmacother. 2006;40:1400–6.CrossRefPubMed Christensen DB, Farris KB. Pharmaceutical care in community pharmacies: practice and research in the US. Ann Pharmacother. 2006;40:1400–6.CrossRefPubMed
12.
go back to reference Hughes CM, Hawwa AF, Scullin C, Anderson C, Bernsten CB, Bjornsdottir I, et al. Provision of pharmaceutical care by community pharmacists: a comparison across Europe. Pharm World Sci. 2010;32:472–87.CrossRefPubMed Hughes CM, Hawwa AF, Scullin C, Anderson C, Bernsten CB, Bjornsdottir I, et al. Provision of pharmaceutical care by community pharmacists: a comparison across Europe. Pharm World Sci. 2010;32:472–87.CrossRefPubMed
13.
go back to reference Ngorsuraches S, Li SC. Thai pharmacists’ understanding, attitudes, and perceived barriers related to providing pharmaceutical care. Am J Health Syst Pharm. 2006;63(21):144–50.CrossRef Ngorsuraches S, Li SC. Thai pharmacists’ understanding, attitudes, and perceived barriers related to providing pharmaceutical care. Am J Health Syst Pharm. 2006;63(21):144–50.CrossRef
14.
go back to reference Jones EJ, Mackinnon NJ, Tsuyuki RT. Pharmaceutical care in community pharmacies: practice and research in Canada. Ann Pharmacother. 2005;39(9):1527–33.CrossRefPubMed Jones EJ, Mackinnon NJ, Tsuyuki RT. Pharmaceutical care in community pharmacies: practice and research in Canada. Ann Pharmacother. 2005;39(9):1527–33.CrossRefPubMed
15.
go back to reference Dunlop JA, Shaw JP. Community pharmacists’ perspectives on pharmaceutical care implementation in New Zealand. Pharm World Sci. 2002;24(6):224–30.CrossRefPubMed Dunlop JA, Shaw JP. Community pharmacists’ perspectives on pharmaceutical care implementation in New Zealand. Pharm World Sci. 2002;24(6):224–30.CrossRefPubMed
16.
go back to reference Wibowo Y, Berbatis C, Joyce A, Sunderland VB. Analysis of enhanced pharmacy services in rural community pharmacies in Western Australia. Rural Remote Health. 2010;10(3):1400.PubMed Wibowo Y, Berbatis C, Joyce A, Sunderland VB. Analysis of enhanced pharmacy services in rural community pharmacies in Western Australia. Rural Remote Health. 2010;10(3):1400.PubMed
17.
go back to reference Fang Y, Yang S, Feng B, Ni Y, Zhang K. Pharmacists’ perception of pharmaceutical care in community pharmacy: a questionnaire survey in Northwest China. Health Soc Care Community. 2011;19(2):189–97.PubMed Fang Y, Yang S, Feng B, Ni Y, Zhang K. Pharmacists’ perception of pharmaceutical care in community pharmacy: a questionnaire survey in Northwest China. Health Soc Care Community. 2011;19(2):189–97.PubMed
18.
go back to reference Aburuz S, Al-Ghazawi M, Snyder A. Pharmaceutical care in a community-based practice setting in Jordan: where are we now with our attitudes and perceived barriers? Int J Pharm Pract. 2012;20(2):71–9.CrossRefPubMed Aburuz S, Al-Ghazawi M, Snyder A. Pharmaceutical care in a community-based practice setting in Jordan: where are we now with our attitudes and perceived barriers? Int J Pharm Pract. 2012;20(2):71–9.CrossRefPubMed
22.
go back to reference Rossing C, Hansen EH, Krass I. The provision of pharmaceutical care in Denmark: a cross-sectional survey. J Clin Pharm Ther. 2003;28:311–8.CrossRefPubMed Rossing C, Hansen EH, Krass I. The provision of pharmaceutical care in Denmark: a cross-sectional survey. J Clin Pharm Ther. 2003;28:311–8.CrossRefPubMed
23.
go back to reference Ramaswamy-Krishnarajan J, Hill DS. Pharmaceutical care in Canada: an exploratory study of 81 community pharmacies. Can Pharm J/Revue des Pharmaciens du Canada. 2005;138:46–50.CrossRef Ramaswamy-Krishnarajan J, Hill DS. Pharmaceutical care in Canada: an exploratory study of 81 community pharmacies. Can Pharm J/Revue des Pharmaciens du Canada. 2005;138:46–50.CrossRef
24.
go back to reference El Hajj M, Kheir N, Zaidan M, Jewesson P. Pharmacist characteristics, medication use perceptions, and professional satisfaction: a first national survey in the state of Qatar. J Healthc Leadersh. 2011;3:9–28.CrossRef El Hajj M, Kheir N, Zaidan M, Jewesson P. Pharmacist characteristics, medication use perceptions, and professional satisfaction: a first national survey in the state of Qatar. J Healthc Leadersh. 2011;3:9–28.CrossRef
25.
go back to reference Roughead L, Semple S, Vitry AI. Pharmaceutical care services: a systematic review of published studies, 1990–2003, examining effectiveness to improve patient outcomes. Int J Pharm Pract. 2005;13:53–70.CrossRef Roughead L, Semple S, Vitry AI. Pharmaceutical care services: a systematic review of published studies, 1990–2003, examining effectiveness to improve patient outcomes. Int J Pharm Pract. 2005;13:53–70.CrossRef
26.
go back to reference El Hajj MS, Hamid Y. Breast cancer health promotion in Qatar: a survey of community pharmacists’ interests and needs. Int J Clin Pharm. 2011;33(1):70–9.CrossRefPubMed El Hajj MS, Hamid Y. Breast cancer health promotion in Qatar: a survey of community pharmacists’ interests and needs. Int J Clin Pharm. 2011;33(1):70–9.CrossRefPubMed
27.
go back to reference El Hajj MS, Al Nakeeb RR, Al-Qudah RA. Smoking cessation counseling in Qatar: community pharmacists’ attitudes, role perceptions and practices. Int J Clin Pharm. 2012;34(4):667–76.CrossRefPubMed El Hajj MS, Al Nakeeb RR, Al-Qudah RA. Smoking cessation counseling in Qatar: community pharmacists’ attitudes, role perceptions and practices. Int J Clin Pharm. 2012;34(4):667–76.CrossRefPubMed
28.
go back to reference Hepler CD. Clinical pharmacy, pharmaceutical care, and the quality of drug therapy. Pharmacotherapy. 2004;24(11):1491–8.CrossRefPubMed Hepler CD. Clinical pharmacy, pharmaceutical care, and the quality of drug therapy. Pharmacotherapy. 2004;24(11):1491–8.CrossRefPubMed
29.
go back to reference Arifi MN, Al-Dhuwaili AA, Gubara OA, Al-Omar HA, Al-Sultan MS, Saeed RIM. Pharmacists’ understanding and attitudes towards pharmaceutical care in Saudi Arabia. Saudi Pharm J. 2007;15(2):146–59. Arifi MN, Al-Dhuwaili AA, Gubara OA, Al-Omar HA, Al-Sultan MS, Saeed RIM. Pharmacists’ understanding and attitudes towards pharmaceutical care in Saudi Arabia. Saudi Pharm J. 2007;15(2):146–59.
30.
go back to reference Oparah AC, Eferakeya AE. Attitudes of Nigerian pharmacists towards pharmaceutical care. Pharm World Sci. 2005;27(3):208–14.CrossRefPubMed Oparah AC, Eferakeya AE. Attitudes of Nigerian pharmacists towards pharmaceutical care. Pharm World Sci. 2005;27(3):208–14.CrossRefPubMed
31.
go back to reference Berbatis CG, Sunderland VB, Joyce A, Bulsara M, Mills C. Enhanced pharmacy services, barriers and facilitators in Australia’s community pharmacies: Australia’s national pharmacy database project. Int J Pharm Pract. 2007;15(3):185–91.CrossRef Berbatis CG, Sunderland VB, Joyce A, Bulsara M, Mills C. Enhanced pharmacy services, barriers and facilitators in Australia’s community pharmacies: Australia’s national pharmacy database project. Int J Pharm Pract. 2007;15(3):185–91.CrossRef
32.
go back to reference Brazinha I, Fernandez-Llimos F. Barriers to the implementation of advanced clinical pharmacy services at Portuguese hospitals. Int J Clin Pharm. 2014;36(5):1031–8.CrossRefPubMed Brazinha I, Fernandez-Llimos F. Barriers to the implementation of advanced clinical pharmacy services at Portuguese hospitals. Int J Clin Pharm. 2014;36(5):1031–8.CrossRefPubMed
33.
go back to reference Uema SA, Vega EM, Armando PD, Fontana D. Barriers to pharmaceutical care in Argentina. Pharm World Sci. 2008;30(3):211–5.CrossRefPubMed Uema SA, Vega EM, Armando PD, Fontana D. Barriers to pharmaceutical care in Argentina. Pharm World Sci. 2008;30(3):211–5.CrossRefPubMed
34.
go back to reference Gastelurrutia MA, Faus MJ, Fernández-Llimós F. Providing patient care in community pharmacies in Spain. Ann Pharmacother. 2005;39(12):2105–10.CrossRefPubMed Gastelurrutia MA, Faus MJ, Fernández-Llimós F. Providing patient care in community pharmacies in Spain. Ann Pharmacother. 2005;39(12):2105–10.CrossRefPubMed
Metadata
Title
Qatar pharmacists’ understanding, attitudes, practice and perceived barriers related to providing pharmaceutical care
Authors
Maguy Saffouh El Hajj
Hassna Sohil AL-Saeed
Maryam Khaja
Publication date
01-04-2016
Publisher
Springer International Publishing
Published in
International Journal of Clinical Pharmacy / Issue 2/2016
Print ISSN: 2210-7703
Electronic ISSN: 2210-7711
DOI
https://doi.org/10.1007/s11096-016-0246-0

Other articles of this Issue 2/2016

International Journal of Clinical Pharmacy 2/2016 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.